Sacubitril Valsartan Sodium/Entresto(LCZ696)

Xi'an Huawave Biotech Co., Ltd. is a professional Sacubitril Valsartan Sodium manufacturer and Sacubitril Valsartan Sodium/ Entresto(LCZ696) supplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
The efficacy of Sacubitril Valsartan Sodium/Entresto(LCZ696) can be summarized as follows:

1. Antihypertensive Effect

Sacubitril Valsartan Sodium contains Valsartan, an angiotensin receptor blocker (ARB), which effectively inhibits the action of angiotensin II, thereby exerting an antihypertensive effect. This medication is used in the treatment of primary hypertension, helping patients stabilize their blood pressure and prevent the continuous rise of blood pressure, which in turn can prevent the progression of heart failure.

2. Treatment of Heart Failure

Sacubitril, another component of Sacubitril Valsartan Sodium, is a neprilysin inhibitor that inhibits the degradation of natriuretic peptides, thereby increasing their levels in the body. This leads to natriuresis and diuresis, improving water and sodium retention. At the same time, it effectively counteracts the harmful effects of the renin-angiotensin system and sympathetic nerve activation, achieving natriuresis, diuresis, and vasodilatation. This, in turn, slows down left ventricular remodeling, improves cardiac function, and alleviates symptoms of chest pain. Therefore, Sacubitril Valsartan Sodium is particularly suitable for heart failure patients with hypertension. It can improve the long-term prognosis of patients, enhance their quality of life, and reduce the hospitalization rate and mortality rate of heart failure patients.

3. Precautions for Use

• Sacubitril Valsartan Sodium should not be used in combination with ACE inhibitors, and it is contraindicated in patients with liver insufficiency or in the middle to late stages of pregnancy.
• Possible adverse reactions include angioedema, hypotension, renal impairment, hyperkalemia, cough, dizziness, etc. Therefore, during medication, it is necessary to closely monitor changes in blood pressure, potassium levels, and renal function.
• During medication, patients should follow a low-salt and low-fat diet and avoid high-calorie foods.

In summary, Sacubitril Valsartan Sodium has significant antihypertensive and heart failure treatment efficacy. However, it should be used reasonably under the guidance of a doctor, with close monitoring of relevant indicators. Meanwhile, patients should also pay attention to diet and lifestyle adjustments during medication.

The primary uses of Sacubitril Valsartan Sodium (also known as Entresto) are as follows:

1. Treatment of Hypertension:
   • Sacubitril Valsartan Sodium is effective in lowering blood pressure, making it a suitable option for the treatment of primary hypertension.
   • It is particularly useful in elderly patients, patients with salt-sensitive hypertension, hypertension combined with heart failure, hypertension with left ventricular hypertrophy, hypertension with chronic kidney disease (stages 1-3), and hypertension with obesity.
2. Management of Chronic Heart Failure:
   • Sacubitril Valsartan Sodium has been shown to improve outcomes in patients with chronic heart failure and a reduced ejection fraction.
   • It can reduce the risk of cardiovascular mortality and hospitalization due to heart failure exacerbations.
   • It is recommended for patients with heart failure who have previously been treated with ACE inhibitors/ARBs, as well as for those who are initiating treatment and have no contraindications to its use.

The drug works by inhibiting the angiotensin II type 1 (AT1) receptor and enhancing the effects of natriuretic peptides, leading to vasodilation, increased glomerular filtration rate, natriuresis, and diuresis. It is important to note that Sacubitril Valsartan Sodium should be used under the guidance of a healthcare professional, as it may cause adverse reactions such as hypotension, hyperkalemia, renal impairment, and angioedema. Regular monitoring of blood pressure, renal function, and serum potassium levels is recommended during treatment.

Overall, Sacubitril Valsartan Sodium is a valuable therapeutic option for the treatment of hypertension and chronic heart failure, offering significant benefits in terms of reducing morbidity and mortality.